Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • moneynow27 moneynow27 Sep 18, 2013 11:40 PM Flag

    The reason why AEGR is in a downtrend.....

    The company has a $2.5B market cap when lead drug profits are years away. In other words, the stock is way ahead of itself. The CEO and giddy analysts can promote the stock all they the end of the day, when no one wants to bid the stock up higher with profits years away, the stock falls.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • There's also recent talk about the prohibitive cost of juxtapid, and possible reimbursement issues down the road. Today is showing a slight technical bounce in the stock, so only time will tell if this downtrend becomes protracted, or just a temporary pullback.

      By the way, for those here who think I'm someone else or the alias of a previous poster, I'm not. Most traders enjoy a substantive discussion that highlights both sides of the trade. I don't have any position in AEGR, and I certainly wouldn't go short for several reasons. I'm long ISIS......

    • system_architect_enterprise system_architect_enterprise Sep 19, 2013 6:09 AM Flag

      Looks like Arthur/Censored put up a new alias. Profits aren't years away, they are already going to be profitable NEXT YEAR. - 2014, which is 3.25 months away. All analyst estimates show this.

      Sheesh, your lies keep getting more outrageous and easier to disprove.

1.41-0.13(-8.44%)Jun 27 4:00 PMEDT